Adventapharma
1 products tracked · names used in filings: Adventapharma
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 25 Sep 2026🇺🇸 FDA approval
FDA approves Zueino (diclofenac sodium): new formulation or manufacturer
Adventapharma; NDA218379; New formulation or manufacturer; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Zueino diclofenac sodium | Approved | 2026-09-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.